Global MSI-H/dMMR Market By Treatment Type (Immune Checkpoint Inhibitors (ICIs) and Combination Therapy), By Stage (Early Stages (Stage I and II) and Advanced Stages (Stage III and IV)), By Indication (Endometrial, Gastric, Colorectal Cancer, Small Intestine Cancer, Cervical Cancer and Others), By End-User (Hospitals, Oncology Clinics, Research Institutions, and Homecare), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: March 2025
- Report ID: 140940
- Number of Pages: 200
- Format:
-
-
-
- Pfizer Inc Company Profile
- Merck & Co.
- AstraZeneca Plc Company Profile
- F. Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GSK plc.
- BeiGene LTD.
- Summit Therapeutics Inc.
- Sanofi Company Profile
- Novartis AG Company Profile
- AbbVie Inc. Company Profile
- Amgen Inc.
- Johnson & Johnson Services, Inc.
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible